Gene · 4591
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity. | Res Sq | 2025 | 40766251 | PubTator, text mining | PubMed |
| The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review. | Cancers (Basel) | 2025 | 40723250 | PubTator, text mining | PubMed |
| Advances in dual energy computed tomography approach for proton stopping power ratio computation in radiotherapy. | World J Radiol | 2025 | 40606054 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel N-(1H-indazol-6-yl)benzenesulfonamide derivatives as potent PLK4 inhibitors. | RSC Med Chem | 2025 | 40521341 | PubTator, text mining | PubMed |
| Letter to Editor: Preoperative membranous urethra length and urinary continence following radical prostatectomy: a systematic review and meta-analysis. | Int J Surg | 2025 | 40511918 | PubTator, text mining | PubMed |
| TRIM37 prevents ectopic spindle pole assembly by peptide motif recognition and substrate-dependent oligomerization. | Nat Struct Mol Biol | 2025 | 40415024 | PubTator, text mining | PubMed |
| Mesoscale regulation of microtubule-organizing centers by the E3 ligase TRIM37. | Nat Struct Mol Biol | 2025 | 40415023 | PubTator, text mining | PubMed |
| Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. | J Med Chem | 2025 | 40378279 | PubTator, text mining | PubMed |
| Newborn Screening Followed By Early Treatment is Essential to Improve Survival in SCID. | J Clin Immunol | 2025 | 40374985 | PubTator, text mining | PubMed |
| PLK4: Master Regulator of Centriole Duplication and Its Therapeutic Potential. | Cytoskeleton (Hoboken) | 2025 | 40257113 | PubTator, text mining | PubMed |
| TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. | Cell Death Dis | 2025 | 40223081 | PubTator, text mining | PubMed |
| Activation of TRIM37 by ATF6 and degradation of ACSL4: inhibiting ferroptosis and propelling cervical cancer progression. | Hereditas | 2025 | 40158112 | PubTator, text mining | PubMed |
| The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women. | EMBO Rep | 2025 | 39614126 | PubTator, text mining | PubMed |
| Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia. | Clin Genet | 2025 | 39558672 | PubTator, text mining | PubMed |
| Assessment of salivary microRNA by RT-qPCR: Facing challenges in data interpretation for clinical diagnosis. | PLoS One | 2024 | 39656703 | PubTator, text mining | PubMed |
| Characteristic roadmap of linker governs the rational design of PROTACs. | Acta Pharm Sin B | 2024 | 39525578 | PubTator, text mining | PubMed |
| Nonlinear edge transport in a quantum Hall system. | Sci Adv | 2024 | 39453998 | PubTator, text mining | PubMed |
| Magnetic nanobead assisted the dual targets driven fluorescent biosensor based on SPEXPAR and MNAzyme for the olfactory marker protein detection. | Mater Today Bio | 2024 | 39403314 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma. | Cell Death Discov | 2024 | 39349442 | PubTator, text mining | PubMed |
| KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer. | Cell Death Discov | 2024 | 39349439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/papers?page=3